Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial

INTRODUCTION: Metformin has been demonstrated to enhance cardioprotective benefits in type 1 diabetes (T1DM). Although glycemic variability (GV) is associated with increased risk of CVD in diabetes, there is a scarcity of research evaluating the effect of metformin on GV in T1DM. OBJECTIVES: In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiuzhen, Xu, Dan, Xu, Ping, Yang, Shufen, Zhang, Qingmei, Wu, Yan, Yuan, Fengyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428086/
https://www.ncbi.nlm.nih.gov/pubmed/34343108
http://dx.doi.org/10.1530/EC-21-0146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428086/
https://www.ncbi.nlm.nih.gov/pubmed/34343108
http://dx.doi.org/10.1530/EC-21-0146

Ejemplares similares